Cargando…

Biguanide Pharmaceutical Formulations and the Applications of Bile Acid-Based Nano Delivery in Chronic Medical Conditions

Biguanides, particularly the widely prescribed drug metformin, have been marketed for many decades and have well-established absorption profiles. They are commonly administered via the oral route and, despite variation in oral uptake, remain commonly prescribed for diabetes mellitus, typically type...

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, Melissa, Ionescu, Corina Mihaela, Walker, Daniel, Wagle, Susbin Raj, Kovacevic, Bozica, Chester, Jacqueline, Foster, Thomas, Johnston, Edan, Kuthubutheen, Jafri, Brown, Daniel, Atlas, Marcus D., Mikov, Momir, Mooranian, Armin, Al-Salami, Hani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8775521/
https://www.ncbi.nlm.nih.gov/pubmed/35055022
http://dx.doi.org/10.3390/ijms23020836
_version_ 1784636606036049920
author Jones, Melissa
Ionescu, Corina Mihaela
Walker, Daniel
Wagle, Susbin Raj
Kovacevic, Bozica
Chester, Jacqueline
Foster, Thomas
Johnston, Edan
Kuthubutheen, Jafri
Brown, Daniel
Atlas, Marcus D.
Mikov, Momir
Mooranian, Armin
Al-Salami, Hani
author_facet Jones, Melissa
Ionescu, Corina Mihaela
Walker, Daniel
Wagle, Susbin Raj
Kovacevic, Bozica
Chester, Jacqueline
Foster, Thomas
Johnston, Edan
Kuthubutheen, Jafri
Brown, Daniel
Atlas, Marcus D.
Mikov, Momir
Mooranian, Armin
Al-Salami, Hani
author_sort Jones, Melissa
collection PubMed
description Biguanides, particularly the widely prescribed drug metformin, have been marketed for many decades and have well-established absorption profiles. They are commonly administered via the oral route and, despite variation in oral uptake, remain commonly prescribed for diabetes mellitus, typically type 2. Studies over the last decade have focused on the design and development of advanced oral delivery dosage forms using bio nano technologies and novel drug carrier systems. Such studies have demonstrated significantly enhanced delivery and safety of biguanides using nanocapsules. Enhanced delivery and safety have widened the potential applications of biguanides not only in diabetes but also in other disorders. Hence, this review aimed to explore biguanides’ pharmacokinetics, pharmacodynamics, and pharmaceutical applications in diabetes, as well as in other disorders.
format Online
Article
Text
id pubmed-8775521
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-87755212022-01-21 Biguanide Pharmaceutical Formulations and the Applications of Bile Acid-Based Nano Delivery in Chronic Medical Conditions Jones, Melissa Ionescu, Corina Mihaela Walker, Daniel Wagle, Susbin Raj Kovacevic, Bozica Chester, Jacqueline Foster, Thomas Johnston, Edan Kuthubutheen, Jafri Brown, Daniel Atlas, Marcus D. Mikov, Momir Mooranian, Armin Al-Salami, Hani Int J Mol Sci Review Biguanides, particularly the widely prescribed drug metformin, have been marketed for many decades and have well-established absorption profiles. They are commonly administered via the oral route and, despite variation in oral uptake, remain commonly prescribed for diabetes mellitus, typically type 2. Studies over the last decade have focused on the design and development of advanced oral delivery dosage forms using bio nano technologies and novel drug carrier systems. Such studies have demonstrated significantly enhanced delivery and safety of biguanides using nanocapsules. Enhanced delivery and safety have widened the potential applications of biguanides not only in diabetes but also in other disorders. Hence, this review aimed to explore biguanides’ pharmacokinetics, pharmacodynamics, and pharmaceutical applications in diabetes, as well as in other disorders. MDPI 2022-01-13 /pmc/articles/PMC8775521/ /pubmed/35055022 http://dx.doi.org/10.3390/ijms23020836 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Jones, Melissa
Ionescu, Corina Mihaela
Walker, Daniel
Wagle, Susbin Raj
Kovacevic, Bozica
Chester, Jacqueline
Foster, Thomas
Johnston, Edan
Kuthubutheen, Jafri
Brown, Daniel
Atlas, Marcus D.
Mikov, Momir
Mooranian, Armin
Al-Salami, Hani
Biguanide Pharmaceutical Formulations and the Applications of Bile Acid-Based Nano Delivery in Chronic Medical Conditions
title Biguanide Pharmaceutical Formulations and the Applications of Bile Acid-Based Nano Delivery in Chronic Medical Conditions
title_full Biguanide Pharmaceutical Formulations and the Applications of Bile Acid-Based Nano Delivery in Chronic Medical Conditions
title_fullStr Biguanide Pharmaceutical Formulations and the Applications of Bile Acid-Based Nano Delivery in Chronic Medical Conditions
title_full_unstemmed Biguanide Pharmaceutical Formulations and the Applications of Bile Acid-Based Nano Delivery in Chronic Medical Conditions
title_short Biguanide Pharmaceutical Formulations and the Applications of Bile Acid-Based Nano Delivery in Chronic Medical Conditions
title_sort biguanide pharmaceutical formulations and the applications of bile acid-based nano delivery in chronic medical conditions
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8775521/
https://www.ncbi.nlm.nih.gov/pubmed/35055022
http://dx.doi.org/10.3390/ijms23020836
work_keys_str_mv AT jonesmelissa biguanidepharmaceuticalformulationsandtheapplicationsofbileacidbasednanodeliveryinchronicmedicalconditions
AT ionescucorinamihaela biguanidepharmaceuticalformulationsandtheapplicationsofbileacidbasednanodeliveryinchronicmedicalconditions
AT walkerdaniel biguanidepharmaceuticalformulationsandtheapplicationsofbileacidbasednanodeliveryinchronicmedicalconditions
AT waglesusbinraj biguanidepharmaceuticalformulationsandtheapplicationsofbileacidbasednanodeliveryinchronicmedicalconditions
AT kovacevicbozica biguanidepharmaceuticalformulationsandtheapplicationsofbileacidbasednanodeliveryinchronicmedicalconditions
AT chesterjacqueline biguanidepharmaceuticalformulationsandtheapplicationsofbileacidbasednanodeliveryinchronicmedicalconditions
AT fosterthomas biguanidepharmaceuticalformulationsandtheapplicationsofbileacidbasednanodeliveryinchronicmedicalconditions
AT johnstonedan biguanidepharmaceuticalformulationsandtheapplicationsofbileacidbasednanodeliveryinchronicmedicalconditions
AT kuthubutheenjafri biguanidepharmaceuticalformulationsandtheapplicationsofbileacidbasednanodeliveryinchronicmedicalconditions
AT browndaniel biguanidepharmaceuticalformulationsandtheapplicationsofbileacidbasednanodeliveryinchronicmedicalconditions
AT atlasmarcusd biguanidepharmaceuticalformulationsandtheapplicationsofbileacidbasednanodeliveryinchronicmedicalconditions
AT mikovmomir biguanidepharmaceuticalformulationsandtheapplicationsofbileacidbasednanodeliveryinchronicmedicalconditions
AT mooranianarmin biguanidepharmaceuticalformulationsandtheapplicationsofbileacidbasednanodeliveryinchronicmedicalconditions
AT alsalamihani biguanidepharmaceuticalformulationsandtheapplicationsofbileacidbasednanodeliveryinchronicmedicalconditions